Patents by Inventor William K. Day
William K. Day has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210085855Abstract: A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.Type: ApplicationFiled: September 2, 2020Publication date: March 25, 2021Inventors: Anatoly S. Belkin, William K. Day, Steve J. Lindo, James P. Roman, Andrei T. Stratan
-
Patent number: 10765799Abstract: A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.Type: GrantFiled: May 24, 2017Date of Patent: September 8, 2020Assignee: ICU Medical, Inc.Inventors: Anatoly S. Belkin, William K. Day, Steve J. Lindo, James P. Roman, Andrei T. Stratan
-
Patent number: 10463788Abstract: A patient care system has a medical pump for delivering a medicine to a patient, and a processor in communication with the pump. The pump is configured to receive a first input on whether the medicine is a critical medicine, and a second input on a trigger condition that triggers a fail-operate mode for the critical medicine. The processor controls the medical pump to operate in the fail-operate mode, where the fail-operate mode continues delivery of the critical medicine when the trigger condition is triggered.Type: GrantFiled: July 31, 2013Date of Patent: November 5, 2019Assignee: ICU Medical, Inc.Inventor: William K. Day
-
Publication number: 20170319780Abstract: A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.Type: ApplicationFiled: May 24, 2017Publication date: November 9, 2017Inventors: Anatoly S. Belkin, William K. Day, Steve J. Lindo, James P. Roman, Andrei T. Stratan
-
Patent number: 9662436Abstract: A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.Type: GrantFiled: September 18, 2014Date of Patent: May 30, 2017Assignee: ICU Medical, Inc.Inventors: Anatoly S. Belkin, William K. Day, Steve J. Lindo, James P. Roman, Andrei T. Stratan
-
Patent number: 9333291Abstract: Enables an infusion pump battery capacity management and battery charge alert system and method including an infusion pump with rechargeable batteries, a controller, a computer and a user interface. The infusion pump accepts a programmed infusion and selects a battery capacity assessment option to determine one or more recharge options of the batteries, and may optionally select a program delay option to execute an infusion delay and later select the battery capacity assessment option. During the battery capacity assessment option, the infusion pump calculates an anticipated power capacity requirement to execute the programmed infusion, calculates a remaining battery power capacity, compares the calculated anticipated power capacity requirement to the calculated remaining battery power capacity, and determines whether the infusion pump is able to fully execute the programmed infusion based only on the remaining battery power capacity or whether a recharge is required.Type: GrantFiled: January 16, 2015Date of Patent: May 10, 2016Assignee: Hospira, Inc.Inventors: James D. Jacobson, Tadas S. Sileika, William K. Day
-
Publication number: 20150196709Abstract: Enables an infusion pump battery capacity management and battery charge alert system and method including an infusion pump with rechargeable batteries, a controller, a computer and a user interface. The infusion pump accepts a programmed infusion and selects a battery capacity assessment option to determine one or more recharge options of the batteries, and may optionally select a program delay option to execute an infusion delay and later select the battery capacity assessment option. During the battery capacity assessment option, the infusion pump calculates an anticipated power capacity requirement to execute the programmed infusion, calculates a remaining battery power capacity, compares the calculated anticipated power capacity requirement to the calculated remaining battery power capacity, and determines whether the infusion pump is able to fully execute the programmed infusion based only on the remaining battery power capacity or whether a recharge is required.Type: ApplicationFiled: January 16, 2015Publication date: July 16, 2015Inventors: James D. Jacobson, Tadas S. Sileika, William K. Day
-
Publication number: 20150088070Abstract: A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.Type: ApplicationFiled: September 18, 2014Publication date: March 26, 2015Inventors: Anatoly S. Belkin, William K. Day, Steve J. Lindo, James P. Roman, Andrei T. Stratan
-
Publication number: 20140039446Abstract: A patient care system has a medical pump for delivering a medicine to a patient, and a processor in communication with the pump. The pump is configured to receive a first input on whether the medicine is a critical medicine, and a second input on a trigger condition that triggers a fail-operate mode for the critical medicine. The processor controls the medical pump to operate in the fail-operate mode, where the fail-operate mode continues delivery of the critical medicine when the trigger condition is triggered.Type: ApplicationFiled: July 31, 2013Publication date: February 6, 2014Inventor: William K. Day